Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Baylor Genetics, Houston, Texas.
Curr Protoc Hum Genet. 2020 Jun;106(1):e99. doi: 10.1002/cphg.99.
As genome sequencing methodologies have become more sensitive in detecting low-frequency rare-variant events, the link between post-zygotic mutagenesis and somatic mosaicism in the etiology of several human genetic conditions other than cancers has become more clear. Given that current clinical-genomics diagnostic methods have limited detection sensitivity for mosaic events, a copy-number variant (CNV) deletion inherited from a parent with low-level (<10%) mosaicism can be erroneously interpreted in the proband to represent a de novo germline event. Here, we describe three sensitive, precise, and cost-efficient methods that can quantitatively assess the potential degree of parental somatic mosaicism levels for CNV deletions: droplet digital PCR (ddPCR), PCR amplicon-based next-generation sequencing (NGS), and quantitative PCR. ddPCR using the EvaGreen fluorescent dye protocol can specifically quantify the deleted or non-deleted alleles by analyzing the number of droplets positive for a fluorescent signal for each event. PCR amplicon-based NGS assesses the allele frequencies of a heterozygous single-nucleotide polymorphism within a deletion region. The difference in number of reads between the two genotypes indicates the level of somatic mosaicism for the CNV deletion. Quantitative PCR can be applied where the relative quantity of the deletion junction-specific product represents the level of mosaicism. Clinical implementation of these quantitative variant-detection methods enables potentially more accurate assessment of disease recurrence risk in family-based genetic counseling, allowing couples to engage in more informed family planning. © 2020 by John Wiley & Sons, Inc. Basic Protocol: Droplet digital PCR (ddPCR) Alternate Protocol 1: PCR amplicon-based next-generation sequencing Alternate Protocol 2: Quantitative real-time PCR (qPCR).
随着基因组测序方法在检测低频罕见变异事件方面变得更加敏感,除癌症以外的几种人类遗传疾病中,合子后突变和体体细胞嵌合现象之间的联系变得更加清晰。鉴于当前临床基因组诊断方法对嵌合事件的检测灵敏度有限,来自低水平(<10%)嵌合体父母的拷贝数变异(CNV)缺失可能会在患者中被错误地解释为新生生殖系事件。在这里,我们描述了三种敏感、精确和具有成本效益的方法,可以定量评估 CNV 缺失的潜在父母体细胞嵌合水平:液滴数字 PCR(ddPCR)、基于 PCR 扩增子的下一代测序(NGS)和定量 PCR。使用 EvaGreen 荧光染料方案的 ddPCR 可以通过分析每个事件中荧光信号阳性的液滴数来特异性地量化缺失或非缺失等位基因。基于 PCR 扩增子的 NGS 评估缺失区域内杂合单核苷酸多态性的等位基因频率。两种基因型之间读取数的差异表明 CNV 缺失的体细胞嵌合水平。定量 PCR 可应用于删除连接特异性产物的相对数量代表嵌合水平的情况。这些定量变异检测方法的临床实施可以更准确地评估基于家族的遗传咨询中的疾病复发风险,使夫妇能够进行更明智的家庭规划。© 2020 年由 John Wiley & Sons, Inc. 基本方案:液滴数字 PCR(ddPCR)替代方案 1:基于 PCR 扩增子的下一代测序替代方案 2:定量实时 PCR(qPCR)。